- Home
- ESP vs TLSA Comparison
ESP vs TLSA Comparison
Compare ESP & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- TLSA
- Stock Information
- Founded
- ESP 1928
- TLSA 2013
- Country
- ESP United States
- TLSA United Kingdom
- Employees
- ESP N/A
- TLSA N/A
- Industry
- ESP Industrial Machinery/Components
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- TLSA Health Care
- Exchange
- ESP Nasdaq
- TLSA Nasdaq
- Market Cap
- ESP 129.5M
- TLSA 187.0M
- IPO Year
- ESP N/A
- TLSA 2000
- Fundamental
- Price
- ESP $47.61
- TLSA $1.45
- Analyst Decision
- ESP
- TLSA
- Analyst Count
- ESP 0
- TLSA 0
- Target Price
- ESP N/A
- TLSA N/A
- AVG Volume (30 Days)
- ESP 29.3K
- TLSA 246.7K
- Earning Date
- ESP 05-12-2025
- TLSA 07-22-2025
- Dividend Yield
- ESP 2.11%
- TLSA N/A
- EPS Growth
- ESP 39.20
- TLSA N/A
- EPS
- ESP 2.67
- TLSA N/A
- Revenue
- ESP $45,965,588.00
- TLSA N/A
- Revenue This Year
- ESP N/A
- TLSA N/A
- Revenue Next Year
- ESP N/A
- TLSA N/A
- P/E Ratio
- ESP $17.72
- TLSA N/A
- Revenue Growth
- ESP 29.60
- TLSA N/A
- 52 Week Low
- ESP $20.50
- TLSA $0.63
- 52 Week High
- ESP $49.00
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- ESP 73.32
- TLSA 48.43
- Support Level
- ESP $45.94
- TLSA $1.43
- Resistance Level
- ESP $48.24
- TLSA $1.81
- Average True Range (ATR)
- ESP 1.97
- TLSA 0.09
- MACD
- ESP 0.13
- TLSA -0.02
- Stochastic Oscillator
- ESP 90.14
- TLSA 18.53
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.